Preferred Name |
avanafil |
|
Synonyms |
4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)-1-pyrrolidinyl)-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide |
|
ID |
http://purl.bioontology.org/ontology/MESH/C553414 |
|
altLabel |
4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)-1-pyrrolidinyl)-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide stendra |
|
cui |
C3473125 C2698280 |
|
HM |
D011743 |
|
II |
D054706 |
|
Inverse of RB |
DR5S136IVO |
|
Mapped to | ||
MDA |
20140701 |
|
MeSH Frequency |
69 |
|
MMR |
20140701 |
|
notation |
C553414 |
|
prefLabel |
avanafil |
|
SC |
1 |
|
Scope Statement |
a PDE5 inhibitor |
|
SRC |
Clin Ther 2010 Jun;32(6):1178-87 |
|
TERMUI |
T780526 T780525 T000861366 |
|
TH |
FDA SRS (2013) USAN (19XX) INN (19XX) NLM (2010) NLM (2014) |
|
tui |
T109 T121 |
Create mapping